Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jul 14, 2017
Company News
M Pharmaceutical in-licenses undisclosed compound
...undisclosed drug from an undisclosed company. M Pharmaceutical, which develops technologies for weight management and
female health
...
Read More
BioCentury
|
Jul 8, 2017
Finance
A clinical quarter
...NYSE:TEVA; Tel Aviv:TEVA) / Pfizer Inc. (NYSE:PFE) Fremanezumab Chronic and episodic migraines Submit BLA 2H17
The Female Health Co.
...
Read More
BioCentury
|
Dec 31, 2016
Finance
Delivering takeouts
...Therapeutics Inc. (NASDAQ:TGTX) / LFB S.A. Ublituximab Relapsed or refractory CLL Ph III data 1H17
The Female Health Co.
...
Read More
BioCentury
|
Jul 9, 2007
Company News
Zila board of directors update
...Zila Inc. (ZILA), Phoenix, Ariz. Business: Dental, Diagnostic Appointed: O.B. Parrish, chairman and CEO of
the Female Health Co.
WIR...
Read More
BioCentury
|
Jun 5, 1995
Finance
Another piece in place for Ligand
...over the past year. Those partnerships - with Abbott in inflammation, American Home Products in
female health
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Jul 14, 2017
Company News
M Pharmaceutical in-licenses undisclosed compound
...undisclosed drug from an undisclosed company. M Pharmaceutical, which develops technologies for weight management and
female health
...
Read More
BioCentury
|
Jul 8, 2017
Finance
A clinical quarter
...NYSE:TEVA; Tel Aviv:TEVA) / Pfizer Inc. (NYSE:PFE) Fremanezumab Chronic and episodic migraines Submit BLA 2H17
The Female Health Co.
...
Read More
BioCentury
|
Dec 31, 2016
Finance
Delivering takeouts
...Therapeutics Inc. (NASDAQ:TGTX) / LFB S.A. Ublituximab Relapsed or refractory CLL Ph III data 1H17
The Female Health Co.
...
Read More
BioCentury
|
Jul 9, 2007
Company News
Zila board of directors update
...Zila Inc. (ZILA), Phoenix, Ariz. Business: Dental, Diagnostic Appointed: O.B. Parrish, chairman and CEO of
the Female Health Co.
WIR...
Read More
BioCentury
|
Jun 5, 1995
Finance
Another piece in place for Ligand
...over the past year. Those partnerships - with Abbott in inflammation, American Home Products in
female health
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page